EUROFINS SCIENT (ERFSF)
(Delayed Data from OTC)
$59.22 USD
-3.22 (-5.16%)
Updated Sep 20, 2024 02:54 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
ERFSF 59.22 -3.22(-5.16%)
Will ERFSF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ERFSF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ERFSF
All You Need to Know About EUROFINS SCIENT (ERFSF) Rating Upgrade to Buy
EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?
ERFSF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ERFSF
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2024 Update
Baron International Growth Fund Q2 2024 Shareholder Letter
Giverny Capital Asset Management Q2 2024 Letter
Longleaf Partners Global Fund Q2 2024 Commentary